Best in Biotech 28 Dec 2020
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at…
Themis Bioscience
- Latest Posts
News and Trends 28 May 2020
MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience
The US-based big pharma MSD has entered the race to be the first to develop an effective vaccine for Covid-19…
News and Trends 20 Mar 2020
Themis and Institut Pasteur Join Coronavirus Vaccine Hunt
The Austrian biotech Themis -- specializing in vaccines for infectious and insect-borne diseases -- has jumped on the coronavirus vaccine…
News and Trends 18 Sep 2019
Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase III trial that could lead…
ADVERTISEMENT
News and Trends 22 Aug 2019
Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’
Vienna-based Themis Bioscience will develop vaccine candidates against an undisclosed disease target in partnership with big pharma Merck Sharp &…
News and Trends 4 Jun 2019
Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine
The market is in sight for the first potential vaccine for the chikungunya virus, as the company Themis Bioscience will…
Interview 6 May 2019
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At BIO-Europe Spring 2019, Regina Hodits,…
News and Trends 6 Nov 2018
First Potential Vaccine for Chikungunya Virus Flies Through Phase II
The mosquito-borne chikungunya virus may one day have a vaccine, as an Austrian biotech’s lead candidate gets positive results in…
News and Trends 5 Sep 2017
UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine
UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards Phase III. Originally Published 06/06/2017…
In Depth 25 Jul 2017
Trouble in Paradise: How Biotech is Fighting Tropical Diseases
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech is preparing for the next…
News and Trends 12 Sep 2016
Grüßgott, get to Meet 9 exciting Biotechs from Vienna
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The city has also been at…
News and Trends 2 Sep 2016
Vienna-based Themis Bioscience frontlines vaccine development against emerging diseases
From Switzerland, we depart once again, this time for Vienna. This week, we are visiting Themis Bioscience, our Biotech of…
News and Trends 14 Jul 2016
Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan
Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and…
